Preparation method of tomato with improved fruit hardness

Through gene editing technology, weakening the SlPG2a gene is extended, and the hardness and shelf life of tomato fruits are solved, which solves the problems of fast softening and short shelf life of traditional tomatoes, and achieves better storage and transportation and economic value.

CN118995748APending Publication Date: 2024-11-22TIANJIN GENOVO BIOTECH CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411301100.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Traditional tomato varieties soften quickly under natural conditions, have short shelf life, and lack new materials with storage resistance and economic value.

Method used

Through gene editing technology, a fixed-point gene editing tool is constructed to weaken or knock out the SlPG2a gene in tomato plants, and to extend the hardness and shelf life of tomato fruits.

Benefits of technology

The hardness loss of tomato fruits is achieved, with a better appearance, and a longer shelf life. At the same time, there is basically no difference between the nutrients, color and taste from the wild type.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995748A_ABST
    Figure CN118995748A_ABST
Patent Text Reader

Abstract

The present disclosure is in the field of plant genetic engineering. Specifically, the invention relates to a preparation method of tomatoes with improved fruit hardness, in particular to but not limited to a method for obtaining tomatoes with prolonged shelf life, a method for detecting tomatoes with prolonged shelf life, related primers and kits, and also relates to a method for prolonging shelf life and prolonging shelf life of tomatoes. According to the method provided by the invention, the tomato target sequence is subjected to gene editing by expressing the gene editing tool in the tomato, so that the tomato with prolonged shelf life is obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure belongs to the field of plant genetic engineering, and relates to a method for producing tomatoes with improved fruit firmness, and particularly to, but not limited to, a method for obtaining tomatoes with extended shelf life, a method for detecting tomatoes with extended shelf life, and related primers and kits, and also to tomato plants with extended shelf life and a method for increasing the shelf life of tomatoes. Background Art

[0002] Tomatoes are important fruits and vegetables in China and around the world. The speed of tomato softening has an important impact on its storage and transportation resistance and economic value, and is a key target trait in tomato breeding. Traditional tomato varieties soften quickly under natural conditions and have a short shelf life. It is very necessary to develop new tomato materials with higher hardness and better storage resistance. Summary of the invention

[0003] In order to solve the above technical problems, the present invention designs a site-specific gene editing tool construct, utilizes the gene editing tool to achieve site-specific editing of target genes in tomato plants, and screens out tomato germplasm with a long shelf life.

[0004] Specifically, in a first aspect, the present disclosure provides a tomato plant cell of a modified non-reproductive material, the tomato plant cell comprising a mutated SlPG2a gene, the mutated SlPG2a gene comprising: an insertion or deletion mutation at positions 1928 to 1947 in SEQ ID NO: 14, and / or an insertion or deletion mutation at positions 2009 to 2028 in SEQ ID NO: 14;

[0005] Compared with the wild-type S1PG2a gene, the mutant S1PG2a gene is knocked down or knocked out.

[0006] In an exemplary embodiment provided by the present disclosure, the mutated SlPG2a gene includes: an insertion or deletion of nucleotides between positions 1939 and 1942 in SEQ ID NO:14, and / or an insertion or deletion of nucleotides between positions 2009 and 2014 in SEQ ID NO:14.

[0007] In an exemplary embodiment of the present disclosure, the mutated SlPG2a gene includes: a deletion of nucleotides 1940 to 1941 in SEQ ID NO:14, and / or a deletion of nucleotides 2009 to 2014 in SEQ ID NO:14.

[0008] In an exemplary embodiment of the present disclosure, the tomato plant cell comprises a mutated SlPG2a protein; the amino acid sequence of the mutated SlPG2a protein is shown in SEQ ID NO:4.

[0009] In an embodiment exemplarily provided by the present disclosure, the tomato plant cell comprises a nucleotide sequence for editing the mutated S1PG2a protein.

[0010] In an exemplary embodiment provided by the present disclosure, the genomic sequence of the mutant SlPG2a protein is shown as SEQ ID NO:15, and the CDS sequence of the mutant SlPG2a protein is shown as SEQ ID NO:3.

[0011] In a second aspect, the present disclosure provides a nucleic acid molecule encoding the mutated S1PG2a protein shown in SEQ ID NO:4.

[0012] In an exemplary embodiment provided by the present disclosure, the genome-based nucleic acid molecule is shown as SEQ ID NO:15, and the CDS sequence encoding the mutated SlPG2a protein shown as SEQ ID NO:4 is shown as SEQ ID NO:3.

[0013] In a third aspect, the present disclosure provides a method for obtaining a tomato plant, wherein all or part of the cells of the tomato plant are transformed by gene editing, physical mutagenesis and / or chemical mutagenesis to express the mutated SlPG2a protein shown in SEQ ID NO:4 and / or the endogenous SlPG2a gene of the tomato plant is mutated into the nucleic acid molecule as described above.

[0014] In an exemplary embodiment provided in the present disclosure, the gene editing tool is CRISPR-Cas nuclease or its derivative technology, zinc finger nuclease or its derivative technology (ZFN) or transcription activator-like effector (TALE) or its derivative technology.

[0015] In an exemplary embodiment provided by the present disclosure, the CRISPR-Cas nuclease is a TraC effector protein, preferably an eTraC protein, whose amino acid sequence is shown in the amino acid sequence of SEQ ID NO:13.

[0016] In a fourth aspect, the present disclosure provides a gRNA molecule, comprising a variable DNA recognition region and a Cas effector protein interaction region, the DNA target sequence recognized by the DNA recognition region of the gRNA molecule at least includes SEQ ID NO: 5 or its complementary sequence, and / or the DNA target sequence recognized by the DNA recognition region of the gRNA molecule at least includes SEQ ID NO: 6 or its complementary sequence.

[0017] In an exemplary embodiment provided in the present disclosure, the number of the gRNA molecules is 2, wherein the DNA target sequence recognized by the DNA recognition region of one of the gRNA molecules includes at least SEQ ID NO: 5 or its complementary sequence, and the DNA target sequence recognized by the DNA recognition region of the other gRNA molecule includes at least SEQ ID NO: 6 or its complementary sequence.

[0018] In an exemplary embodiment provided by the present disclosure, the number of the gRNA molecule is 1, and the DNA target sequence recognized by the DNA recognition region of the gRNA molecule includes at least SEQ ID NO: 5 or its complementary sequence.

[0019] In an exemplary embodiment of the present disclosure, the DNA target sequence is located in the S1PG2a gene.

[0020] In a fifth aspect, the present disclosure provides a composition comprising a Cas effector protein and the above-mentioned gRNA.

[0021] In a sixth aspect, the present disclosure provides an expression vector, which encodes the above-mentioned gRNA and Cas effector protein.

[0022] In a seventh aspect, the present disclosure provides a ribonucleoprotein complex, which includes the above-mentioned gRNA and Cas effector protein.

[0023] In an eighth aspect, the present disclosure provides a method for reducing the expression of the SlPG2a gene, the method comprising delivering the above-mentioned vector, or the above-mentioned ribonucleoprotein complex directly or indirectly into a tomato target cell or a tomato target structure.

[0024] In the ninth aspect, the Cas effector protein described in the above-mentioned gRNA molecule, the above-mentioned composition, the above-mentioned vector, the above-mentioned ribonucleoprotein complex or the above-mentioned method for reducing SlPG2a gene expression, wherein the Cas effector protein is a transposon and a CRISPR-Cas12 intermediate (TraC) effector protein.

[0025] In a tenth aspect, the present disclosure provides a tomato plant cell of a modified non-reproductive material, the tomato plant cell comprising: the aforementioned gRNA molecule, the aforementioned composition, the aforementioned vector and / or the aforementioned ribonucleoprotein complex;

[0026] The tomato plant cell also includes: reducing the expression of the SlPG2a gene.

[0027] In an exemplary embodiment of the present disclosure, the expression of the protein shown in SEQ ID NO: 4 is reduced due to the expression of the S1PG2a gene.

[0028] In an exemplary embodiment of the present disclosure, compared with a tomato plant in which the expression of the S1PG2a gene is not reduced, the softening time of tomato fruits of a tomato plant comprising the tomato plant cell is prolonged, that is, the shelf life of the tomato fruits is improved.

[0029] In an eleventh aspect, the present disclosure provides a method for detecting the presence of SlPG2a gene mutant tomatoes, the method comprising: contacting a sample to be detected with at least two primers for amplifying a target amplification product in a nucleic acid amplification reaction;

[0030] performing nucleic acid amplification reactions;

[0031] detecting the presence of the target amplification product;

[0032] The target amplification product comprises the nucleic acid sequence described in SEQ ID NO:9.

[0033] In an embodiment exemplarily provided by the present disclosure, the two primers include primers shown in SEQ ID NO:10 and SEQ ID NO:11.

[0034] In a twelfth aspect, the present disclosure provides a kit for detecting tomatoes with reduced SlPG2a gene expression, the kit comprising primers shown in SEQ ID NO:10 and SEQ ID NO:11.

[0035] Technical Effects

[0036] The present disclosure provides a mutant tomato SlPG2a protein and its encoding gene, and the tomato fruit of the tomato plant with the mutation has a lower rate of change in hardness over time than the wild type, that is, at the same tomato fruit harvest time, the edited tomato fruit has a smaller loss in hardness, a better appearance, and a longer shelf life. Compared with the wild-type tomato fruit, the tomato fruit with the target mutation has basically no difference in nutritional components, color, taste, etc. or their changes over time.

[0037] definition

[0038] In this article, unless otherwise specified, the scientific and technical terms used in this article have the meanings commonly understood by those skilled in the art. In addition, the protein and nucleic acid chemistry, molecular biology, cell and tissue culture, microbiology, immunology related terms and laboratory operation procedures used in this article are terms and routine procedures widely used in the corresponding fields. For example, the standard recombinant DNA and molecular cloning techniques used in this disclosure are well known to those skilled in the art and are more fully described in the following documents: Sambrook, J., Fritsch, EF and Maniatis, T., Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter referred to as "Sambrook"). At the same time, in order to better understand the present disclosure, the definitions and explanations of the relevant terms are provided below.

[0039] As used herein, the term "and / or" encompasses all combinations of items connected by the term, and each combination should be considered to have been listed separately herein. For example, "A and / or B" encompasses "A," "A and B," and "B." For example, "A, B, and / or C" encompasses "A," "B," "C," "A and B," "A and C," "B and C," and "A and B and C."

[0040] As used herein, the terms "comprising", "including" and "comprising" should be understood to mean at least having the features specified therein, while not excluding any other unspecified features. The term "plant" as used herein includes immature or mature whole tomato plants, including plants from which seeds, grains or anthers have been removed. Any seed or embryo capable of producing a plant is also considered a tomato plant.

[0041] As used herein, the terms "gene", "genome" encompass not only the chromosomal DNA present in the cell nucleus, but also the organelle DNA present in the subcellular components of the cell (eg, mitochondria, plastids).

[0042] "Genetically modified organism" or "genetically modified cell" means an organism or cell that contains an exogenous polynucleotide or a modified gene or expression control sequence in its genome. For example, the exogenous polynucleotide can be stably integrated into the genome of the organism or cell and inherited for consecutive generations. The exogenous polynucleotide can be integrated into the genome alone or as part of a recombinant DNA construct. The modified gene or expression control sequence is a sequence in the genome of the organism or cell that contains single or multiple deoxynucleotide substitutions, deletions and additions.

[0043] As used herein, "polynucleotide", "nucleic acid sequence", "nucleotide sequence", "DNA sequence" or "nucleic acid fragment" are used interchangeably and are single-stranded or double-stranded RNA or DNA polymers, optionally containing synthetic, non-natural or altered nucleotide bases. Nucleotides are referred to by their single letter names as follows: "A" is adenosine or deoxyadenosine (RNA or DNA, respectively), "C" represents cytidine or deoxycytidine, "G" represents guanosine or deoxyguanosine, "U" represents uridine, "T" represents deoxythymidine, "R" represents purine (A or G), "Y" represents pyrimidine (C or T), "K" represents G or T, "H" represents A or C or T, "I" represents inosine, and "N" represents any nucleotide.

[0044] As used herein, a polynucleotide is an isolated polynucleotide. Also provided are biological samples and tomato byproducts comprising any of the above polynucleotides. In certain embodiments, the byproduct is a processed product made from a tomato plant or its fruit with a mutated SlPG2a gene, including: (a) fresh or dried tomato fruit; (b) extracts such as extracted lycopene and its derivatives; (c) tomato fermentation products such as tomato-containing wine; (d) tomato-based animal feed or human food (e.g., tomato juice, tomato sauce, tomato paste and other tomato foods, and feed containing tomatoes), (e) medicines; (f) unprocessed or processed biomass (such as tomato stems and leaves or compost thereof); and (g) various industrial products.

[0045] As used herein, "polypeptide", "peptide", "amino acid sequence" and "protein" are used interchangeably in the present disclosure to refer to a polymer of amino acid residues. The terms apply to amino acid polymers in which one or more amino acid residues is an artificial chemical analog of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers. The terms "polypeptide", "peptide", "amino acid sequence" and "protein" may also include modified forms, including but not limited to glycosylation, lipid attachment, sulfation, gamma carboxylation of glutamic acid residues, hydroxylation and ADP-ribosylation.

[0046] Sequence "identity" has a meaning recognized in the art, and the percentage of sequence identity between two nucleic acid or polypeptide molecules or regions can be calculated using published techniques. Sequence identity can be measured along the full length of a polynucleotide or polypeptide or along a region of the molecule. (See, for example: Computational Molecular Biology, Lesk, AM, ed., Oxford University Press, New York, 1988; Biocomputing: Informatics and Genome Projects, Smith, DW, ed., Academic Press, New York, 1993; Computer Analysis of Sequence Data, Part I, Griffin, AM, and Griffin, HG, eds., Humana Press, New Jersey, 1994; Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press, 1987; and Sequence Analysis Primer, Gribskov, M. and Devereux, J., eds., M Stockton Press, New York, 1991). Although there are many methods to measure the identity between two polynucleotides or polypeptides, the term "identity" is well known to those of skill (Carrillo, H. & Lipman, D., SIAM J Applied Math 48:1073 (1988)).

[0047] In peptides or proteins, suitable conservative amino acid substitutions are known to those skilled in the art and can generally be made without changing the biological activity of the resulting molecule. Generally, those skilled in the art recognize that single amino acid substitutions in non-essential regions of a polypeptide do not substantially change biological activity (see, e.g., Watson et al., Molecular Biology of the Gene, 4th Edition, 1987, The Benjamin / Cummings Pub. co., p. 224).

[0048] As used herein, "promoter" refers to a nucleic acid fragment that can control the transcription of another nucleic acid fragment. In some embodiments of the present disclosure, a promoter is a promoter that can control the transcription of a gene in a cell, whether or not it is derived from the cell. The promoter can be a constitutive promoter or a tissue-specific promoter or a developmentally regulated promoter or an inducible promoter.

[0049] As used herein, "sample" or "sample" refers to intact or incomplete tomato plant tissue (e.g., crushed tomato fruit or tomato plant tissue, chopped tomato plant tissue, or freeze-dried tissue, etc.). It can also be an extract containing intact or incomplete seeds or tomato plant tissue. The biological sample may include tomato paste, powder, fermentation products, etc. that contain all or part of tomato plant byproducts. In some embodiments, the biological sample is "non-regenerable" (i.e., it cannot be regenerated into a tomato plant or tomato plant part).

[0050] As used herein, "reduced expression of the S1PG2a gene" refers to a mutation that results in loss or reduction of gene function compared to the unmutated or wild-type allele.

[0051] As used herein, "mutation" may be that the position of the double-strand break of the DNA in the genome of SlPG2a is increased by 1bp, 2bp, 3bp, 4bp, 5bp, 6bp, 7bp, 8bp, 9bp, 10bp, 15bp, 20bp, 25bp or more compared with the wild type; the "mutation" may also be that the position of the double-strand break of the DNA in the genome of SlPG2a is decreased by 1bp, 2bp, 3bp, 4bp, 5bp, 6bp, 7bp, 8bp, 9bp, 10bp, 15bp, 20bp, 25bp or more compared with the wild type.

[0052] As used herein, "mutated" or "edited" refers to knocking down or knocking out the endogenous tomato SlPG2a gene, that is, reducing the expression of the SlPG2a gene. In certain embodiments, this knockdown or knockout mutation causes the SlPG2a gene to express a protein as shown in SEQ ID NO: 4. "Mutated" can also refer to mutations in the Cas enzyme to obtain a higher editing efficiency for the target sequence and other beneficial effects related to the Cas enzyme.

[0053] In certain embodiments, the deletion shown in SEQ ID NO: 3 is a SlPG2a null mutation, which includes at least a deletion of nucleotides 1940 to 1941 in SEQ ID NO: 14, and / or a deletion of nucleotides 2009 to 2014 in SEQ ID NO: 14. That is, the CDS sequence of SlPG2a has a deletion of nucleotides 459 and 460 (TA deletion) in SEQ ID NO: 1, and / or a deletion of nucleotides 528 to 533 (CAATGG deletion) in SEQ ID NO: 1.

[0054] As used herein, "plant" or "plant" includes the whole tomato plant and any progeny, cells, tissues, parts or components thereof. Thus, the term "plant" or "plant" includes immature or mature whole tomato plants, including plants or plants from which seeds, fruits or anthers have been removed.

[0055] As used herein, "plant part" includes any part of a plant, such as but not limited to: seeds (including mature seeds and immature seeds); fruits; plant slices; plant cells; plant cell cultures; or plant organs (such as pollen, embryos, flowers, fruits, buds, leaves, roots, stems and explants). Plant tissues or plant organs can be seeds, protoplasts, callus or any other plant cell groups organized into structural or functional units. Plant cells or tissue cultures can regenerate plants with physiological and morphological characteristics of the plant from which the cells or tissues were obtained, and regenerate plants that are substantially identical to the plant genotype. Regenerable cells in plant cells or tissue cultures can be embryos, protoplasts, meristem cells, callus, pollen, leaves, anthers, roots, root tips, flowers or stems. In contrast, some plant cells cannot regenerate to produce plants, which are referred to as "non-reproductive" plant cells.

[0056] In certain embodiments, tomato fruits obtained from tomato plants with knockout or knockout of the SlPG2a gene have a longer softening time (i.e., a longer shelf life) than tomato fruits obtained from corresponding wild-type tomato plants, while the yield of individual tomato plants is increased or unchanged. The softening time can be increased by up to 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, or 50%. The firmness can be increased by up to 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, or 50% at the same harvest time.

[0057] As used herein, "trait" refers to a physiological, morphological, biochemical, or physical characteristic of a cell or organism.

[0058] As used herein, "traits" specifically refer to measurable indicator parameters of crop plants, including but not limited to: leaf green, yield, growth rate, total biomass or accumulation rate, fresh weight at maturity, dry weight at maturity, fruit yield, seed yield, plant total nitrogen content, fruit nitrogen content, seed nitrogen content, plant vegetative tissue nitrogen content, plant total free amino acid content, fruit free amino acid content, seed free amino acid content, plant vegetative tissue free amino acid content, plant total protein content, fruit protein content, seed protein content, plant vegetative tissue protein content, herbicide resistance and drought resistance, nitrogen absorption, root lodging, harvest index, stem lodging, plant height, disease resistance, cold resistance and salt resistance, etc.

[0059] As used herein, "regulating the shelf life of tomatoes", "extending the shelf life of tomatoes", and "extending the shelf life of tomatoes" means that the rate of change of the hardness of tomato fruits of tomato plants with mutations provided by the present disclosure over time is lower than that of wild-type tomato fruits, that is, under the same tomato fruit harvest time, the edited tomato fruits have less hardness loss, better appearance, and extended shelf life. Compared with wild-type tomato fruits, the tomato fruits with the target mutations have basically no difference in nutritional components, color, taste, etc. or their changes over time.

[0060] As used herein, the time in tomato "fruit harvest time" or "over time" refers to days post-harvest (DPH).

[0061] As used herein, "nuclease" refers to a nuclease that completely or partially loses its cleavage activity. In some embodiments, the nuclease of the present disclosure can be selected from a TraC effector protein, preferably an eTraC protein, whose amino acid sequence is shown in the amino acid sequence of SEQ ID NO: 13, and the structure of the gRNA corresponding to the TraC effector protein includes a scaffold. The TraC effector protein and its corresponding gRNA can be described and selected in more detail with reference to Chinese patent CN117187213A. If any of the foregoing definitions is inconsistent with any patent or non-patent reference cited herein, any patent or non-patent reference cited herein, or any patent or non-patent reference elsewhere, it should be understood that the foregoing definitions will be used herein. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] Figure 1 This is the vector map of the p030-0002 vector in Example 1.

[0063] Figure 2 Schematic diagram of the T-DNA insertion region of the vector map of the p030-0002 vector in Example 1.

[0064] Figure 3 To obtain the peak graph (excerpt) and comparative analysis diagram of the test results of the homozygous tomato plant (T1 generation) numbered PG2a-T1-1 for the target mutation, Figure 4 To obtain the peak graphs (excerpts) and comparative analysis diagrams of the test results of homozygous tomato plants (T2 generation) numbered PG2a-T2-1 to PG2a-T2-3 for the target mutation, Figure 5 The peak graphs (excerpts) and comparative analysis diagrams of the test results of homozygous tomato plants (T3 generation) numbered PG2a-T3-1 to PG2a-T3-3 with the target mutation were obtained. It can be seen that 2bp (TA) was deleted in the target region 1 (target sequence, SEQ ID NO:5) of the SlPG2a gene and 6bp (CAATGG) was deleted in the target region 2 (target sequence, SEQ ID NO:6). It can be seen that the deletion of 2bp (TA) in the target region 1 (target sequence, SEQ ID NO:5) ultimately led to the premature termination of protein translation, and the amino acid sequence was truncated from 457aa to 159aa.

[0065] Figure 6 Illustration of a tomato fruit with part of the peel removed from the top.

[0066] Figure 7 These are pictures of tomato fruits with the target mutation and their corresponding wild-type tomato fruits at day 0 of harvest in Example 4.

[0067] Figure 8 This is a statistical graph showing the changes in firmness over time of tomato fruits with the target mutation (endogenous SlPG2a gene mutation expressing SEQ ID NO:4 protein) and corresponding wild-type tomato fruits under the same storage conditions. DETAILED DESCRIPTION

[0068] The present disclosure will now be described with reference to the following examples which are intended to illustrate the present disclosure rather than to limit the present disclosure.

[0069] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0070] In the experimental methods of the following embodiments, unless otherwise specified, 10 strains of each number of the T1 generation and its progeny were randomly selected and mixed into one sample for detection or analysis. If the number was less than 10 strains, the maximum number that was not 1 was taken.

[0071] In the following examples, the tomato buds tolerant to glufosinate show normal green color similar to the wild-type tomato buds not treated with glufosinate, while the wild-type tomato buds treated with the same amount of glufosinate do not show normal green color but yellow color. This indicates that the presence of the glufosinate resistance gene (i.e., the Bar marker gene) makes the tomato buds tolerant to glufosinate.

[0072] The tomato fruit hardness test is performed using a fruit hardness tester (model GY-5A). The measurement method includes removing part of the peel from the top of the tomato fruit, an area of ​​1 cm 2 Left and right, such as Figure 6 When removing the peel, use a sharp blade to only remove the peel without damaging the flesh. Press the hardness tester probe on the peeled area to test the flesh pressure (this can avoid the interference of the peel on the hardness of the tomato fruit and make the test more stable).

[0073] The gene-edited tomatoes and control tomatoes that changed color on the same day and were harvested on the same day were grouped into 8 groups, with 4 tomato fruits in each group. They were stored at 24°C and 60% relative humidity, and the hardness of the tomato fruits was tested on the 0th, 2nd, 4th, 6th, 8th, 10th, and 12th day after harvest. The same-day color change and harvesting means that when the second bunch of tomato fruits changes color, the gene-edited tomatoes and control tomatoes that change color on the same day are marked, and they are harvested 9 days after the color change for trait testing.

[0074] In the following examples, the tomato variety used is Ailsa Craig (AC), a product of the American Tomato Genetic Resource Center (TGRC, http: / / tgrc.ucdavis.edu / ), numbered LA2838A. The reference genome used in the present disclosure is the tomato Ailsa Craig genome and the corresponding annotations are as follows: genome download address http: / / solomics.agis.org.cn / tomato / ftp / genome / TS9.fasta.gz, gene annotation download address http: / / solomics.agis.org.cn / tomato / ftp / gff / TS 9.gff3.gz.

[0075] In the following embodiments, the host cell (recombinant cell) containing the vector is Agrobacterium rhizogenes and / or Agrobacterium tumefaciens, and the Agrobacterium rhizogenes is preferably selected from one or more wild-type or derivative strains thereof of A4, Arqua1, MSU440, C58C1, Ar1193, K599, ATCC15834 and NCPPB1855; Agrobacterium tumefaciens is preferably selected from one or more wild-type or derivative strains thereof of EHA101, EHA105, LBA4404, GV3101 and AGL1, or the un-disarmed strain C58.

[0076] In the following examples, the identification test steps of gene editing are conventional experimental steps in the art. When detecting genome editing sites, the Ailsa Craig (AC) reference genome is used as a primer design template, the sequence shown in SEQ ID NO: 14 is the SlPG2a genome sequence, and SEQ ID NO: 12 is an excerpt of SEQ ID NO: 14. As shown in SEQ ID NO: 12, a pair of primers (i.e., SEQ ID NO: 10 and SEQ ID NO: 11) are designed on both sides of the editing site to amplify the editing of the target site. The genome editing site-specific PCR test primers are shown in Table 1:

[0077] Table 1: Primers for site-specific PCR assays of genome editing conditions

[0078]

[0079] Example 1: Construction of gene editing vector

[0080] Vector construction: The binary vector used in the plant gene editing process in this example is derived from Escherichia coli, which has not yet been reported to be pathogenic or to have the potential to evolve into pathogenicity. Figure 1 The replication origin ori of the vector (as shown in Figure 1) is derived from the natural plasmid of E. coli. The vector contains the eTraC nuclease coding sequence, the gRNA that guides the eTraC protein to anchor to the target gene, and the selection marker Bar gene. The vector map is shown in Figure 1. Figure 1 and Figure 2 shown.

[0081] Genetic transformation of tomato can be accomplished using methods well known in the art, such as the method of Khuong et al. (Khuong et al., 2013) for Agrobacterium-mediated transformation of tomato explants.

[0082] Example 2: Obtaining gene-edited plants

[0083] The target sequence designed for the TraC enzyme is shown in Table 2 below. Gene editing was performed on the target site in Table 2 to obtain the mutant genotype of tomato SlPG2a, as shown in Table 2:

[0084] Table 2: Statistics of gene editing target sequences

[0085]

[0086] According to the target sequence in Table 2, the combination of gRNA in the gene editing system is designed (for example, the combination of the DNA recognition region of the gRNA molecule is SEQ ID NO: 5 and SEQ ID NO: 6), and the plasmid containing the gene editing tool is delivered into the fully expanded cotyledons of tomatoes for genetic transformation, and glufosinate-ammonium is used as a selection marker to identify explants that have grown buds, i.e., tender shoots. The appearance of the tender shoots is observed, and the tolerance of the tender shoots is recorded. Tomato tender shoots tolerant to glufosinate-ammonium are obtained.

[0087] After elongation culture of glufosinate-tolerant tomato shoots, the shoots were transferred to a rooting medium, and the rooted tomato plants were transferred to a greenhouse to obtain rooted seedlings. It was determined whether the vector described in Example 1 was integrated into the tomato genome, and the integrated seedlings were recorded as transgenic seedlings.

[0088] The transgenic seedlings were subjected to second-generation sequencing, and analysis showed that there were plants that had undergone gene editing and plants that had not undergone gene editing. Several plants were selected for phenotypic, off-target and genetic stability analysis.

[0089] Example 3: Phenotypic analysis, off-target and genetic stability analysis

[0090] The transgenic seedlings obtained after gene editing according to the different gene editing target sequences shown in Table 2 were transferred to a greenhouse and grown until T0 generation tomato fruits and T1 generation tomato fruits were obtained. Several tomato plants with the highest hardness at the same harvest time of T1 generation tomato fruits were selected by measurement.

[0091] The analysis found that the SlPG2a gene of multiple T1 tomato plants with the highest fruit hardness at the same harvest time had a target mutation as shown in SEQ ID NO:15 (the CDS sequence of their SlPG2a gene was shown in SEQ ID NO:3), and the gene-edited plants with the target mutation were propagated. The yield, nutrition, color, taste and other aspects of the harvested tomato fruits were basically the same as those of wild-type tomatoes.

[0092] Genomic DNA was extracted from multiple T1 plants with target mutations, and multiple pairs of primers were used to detect whether there were vector residues in the T1 plants. The target gene editing type and potential off-target sites were verified by targeted PCR and sequencing. Finally, the lines with homozygous mutations at the target sites, no exogenous vector sequences remaining, and no editing at the potential target sites and other sites were selected for further self-pollination, and T2 seeds were harvested. T2 seeds were used to plant and harvest T3 seeds.

[0093] Verification of potential off-target sites The crop genome editing target off-target prediction software Cas-OFFinder (v2.4, Sangsu et al., 2014) (http: / / github.com / snugel / cas-offinder) was used to predict the potential off-target sites of sgRNAs targeting the target sequences shown in SEQ ID NO: 5 (i.e., sequence number 1 in Table 3) and SEQ ID NO: 6 (i.e., sequence number 2 in Table 3) in the Ailsa Craig tomato genome, as shown in Table 3. The presence of predicted potential off-targets in the gene-edited transgenic seedlings was analyzed by next-generation sequencing, and the conclusion showed that no off-targets occurred in the potential off-target regions, and the nucleotide sequences were exactly the same as those of the wild type.

[0094] Table 3 Statistics of predictable off-target regions of sgRNA in this example

[0095]

[0096] Since the genome editing site is located inside the target gene, the T1, T2 and T3 generations of the T0 generation tomatoes were identified and tracked according to the primers described in Table 1. The results showed that in the editing materials of the T1, T2 and T3 generations selected in this example, the genome editing site can be stably inherited, does not contain editing elements, has no off-target, and is homozygous for the editing site. Figure 3 , Figure 4 and Figure 5 As shown in the peak diagram, Figure 3 An exemplary description of the T1 generation plant numbered PG2aT1-1 is selected; Figure 4 Exemplary description of the T2 generation plants numbered PG2aT2-1, PG2aT2-2, and PG2aT2-3; Figure 5 Exemplary description of T3 generation plants numbered PG2aT3-1, PG2aT3-2, and PG2aT3-3.

[0097] Figure 3 , Figure 4 and Figure 5 In the figure, the dark-colored sequence is the target sequence region for gene editing to which sgRNA binds. SlPG2a_original is the wild-type control, and the T1 generation is a single plant test; 30 plants were tested in each of the T2 and T3 generations, and 10 plants were mixed into 1, and each was divided into 3 samples (i.e., PG2aT2-1, PG2aT2-2, PG2aT2-3, PG2aT3-1, PG2aT3-2, and PG2aT3-3) for testing. The controls for all generations were the corresponding wild-type tomato Ailsa Craig controls. The experiment used the SlPG2a gene sequence in the tomato Ailsa Craig genome as a template.

[0098] It was identified that the target sequence of SlPG2a gene corresponding to the T1, T2 and T3 generation plants of the recipient tomato Ailsa Craig was missing 2 bp (TA) at the SEQ ID NO:5 target sequence, and 6 bp (CAATGG) at the SEQ ID NO:6 target sequence, which ultimately led to the premature termination of protein translation and the truncation of the amino acid sequence from 457aa (SEQ ID NO:2) to 159 aa (SEQ ID NO:4). Phenotypic and genomic analyses showed that this mutation can significantly slow down tomato softening, extend the shelf life of tomatoes, and increase the firmness of tomato fruits compared to wild-type tomatoes harvested at the same time.

[0099] Example 4: Field trial

[0100] The target mutation, i.e., the SlPG2a gene has undergone gene editing as shown in the sequence of SEQ ID NO: 15 (the CDS sequence of its SlPG2a gene is shown in SEQ ID NO: 3), the subsequent generations of tomato plants with no off-target and editing elements, homozygous editing sites and no other modifications, and its wild type Ailsa Craig (AC) (hereinafter referred to as the control) are selected for field planting, and the changes in the firmness of the tomato fruit over time, the changes in the weight loss of the tomato fruit over time, the changes in the appearance of the tomato fruit over time, and the effects on the nutrients, color, taste and growth of the tomato fruit are analyzed. The changes over time can be selected from time points such as 0 days, 2 days, 4 days, 6 days, 8 days, 10 days, and 12 days after the tomato fruit is harvested. The pictures of tomato fruits with the target mutation on the 0th day of harvest and the corresponding wild-type tomato fruits are exemplified as follows Figure 7 shown.

[0101] The measurement results are as follows Figure 8 As shown, from Figure 8 It can be seen that under the same storage conditions, the hardness of tomatoes with the target mutation (endogenous SlPG2a gene mutation expressing SEQ ID NO:4 protein) has a lower rate of change over time than the wild type. After the tomatoes with the target mutation were harvested, the fruit hardness gradually decreased with the storage time, and the trend was basically the same as that of the control tomatoes. Compared with the control tomatoes for the same storage time, the hardness of the edited tomatoes was significantly higher than that of the control tomatoes. It can be inferred that the edited tomatoes have a longer shelf life.

[0102] according to Figure 8 The linear regression equation of the hardness value was fitted, and the linear regression equation of the hardness value of the target mutant tomato was obtained as y=0.7445-0.0165x, where y is the hardness value in kg / cm 2, x is time, unit is day. The linear regression equation of the hardness value of wild-type tomatoes in the control group is: y=0.6460-0.0145x, where y is the hardness value, unit is kg / cm 2 , x is time, the unit is day.

[0103] According to the above linear regression equation of hardness value, assuming that the hardness of tomato pulp is 0.4kg / cm 2 , the usability quality of tomatoes is affected. It can be inferred that the shelf life of tomato fruits with the target mutation is 2088 days, while the shelf life of wild-type tomato fruits is 16.97 days, that is, the shelf life of tomatoes with the target mutation can be extended by 23%.

[0104] Compared with wild-type tomato fruits, there were no significant differences in the nutritional components, color, taste, etc. of tomato fruits with the target mutation or their changes over time. As can be seen from Table 4, there were no significant differences in single fruit weight, fruit shape, sugar content, acidity, etc. when analyzing the traits of tomato fruits obtained on the day of harvest.

[0105] Table 4: Statistics of single fruit weight, fruit shape, sugar content and acidity

[0106]

[0107] In Table 4, the letters after the numerical values ​​indicate the significant difference between the target mutant tomato and its corresponding wild-type tomato at the α=0.05 level, and the same lowercase letters indicate that the difference is not significant. All data in Table 4 were analyzed by one-way ANOVA using the SPSS system to calculate the significant difference at the α=0.05 level.

[0108] In addition, the deletion of 2bp (TA) in target region 1 (target sequence, SEQ ID NO: 5) can lead to premature termination of SlPG2a protein translation, and the amino acid sequence is truncated from 457aa to 159aa. Regardless of whether the target region 2 (target sequence, SEQ ID NO: 6) is mutated, it will not affect the premature termination of SlPG2a protein translation. In other words, whether the target region 2 (target sequence, SEQ ID NO: 6) is mutated or not, a similar effect of extending the shelf life of tomatoes can be obtained.

[0109] Sequence Listing:

[0110] >SEQ ID NO:1 SlPG2a CDS original (1374 bp):

[0111] ATGGTTATCCAAAGGAATAGTATTCTCCTTCTCATTATTATTTTTGCTTCATCAATTTCAACTTGTAGAAGCAATGTTATTGATGACAATTTATTCAAACAAGTTTATGATAATATTCTTGAACAAGAATTTGCTCATGATTTTCAAGCTTATCTTTCTTATTTGAGCAAAAATATTGAAAGCAACAATAATATTGACAAGGTTGATAAAAATGGGATTAAAGTGATTAATGTACTTAGCTTTGGAGCTAAGGGTGATGGAAAAACATATGATAATATTGCATTTGAGCAAGCATGGAATGAAGCATGTTCATCTAGAACACCTGTTCAATTTGTGGTTCCTAAAAACAAGAATTATCTTCTCAAGCAAATCACCTTTTCAGGTCCATGCAGATCTTCTATTTCAGTAAAGATTTTTGGATCCTTAGAAGCATCTAGTAAAATTTCAGACTACAAAGA TA GAAGGCTTTGGATTGCTTTTGATAGTGTTCAAAATTTAGTTGTTGGAGGAGGAGGAACTATCAATGG CAAT GGACAAGTATGGTGGCCAAGTTCTTGCAAAATAAATAAATCACTGCCATGCAGGGATGCACCAACGGCCTTAACCTTCTGGAATTGCAAAAATTTGAAAGTGAATAATCTAAAGAGTAAAAATGCACAACAAATTCATATCAAATTTGAGTCATGCACTAATGTTGTAGCTTCAAATTTGATGATCAATGCTTCAGCAAAGAGCCCAAATACTGATGGAGTCCATGTATCAAATACTCAATATATTCAAATATCTGATACTATTATTGGAACAGGTGATGATTGTATTTCAATTGTTTCTGGATCTCAAAATGTGCAGGCCACAAATATTACTTGTGGTCCAGGTCATGGTATAAGTATTGGAAGCTTAGGATCTGGAAATTCAGAAGCTTATGTGTCTAATGTTACTGTAAATGAAGCCAA AATTATCGGTGCCGAAAATGGAGTTAGGATCAAGACTTGGCAGGGAGGATCTGGACAAGCTAGCAACATCAAATTTCTGAATGTGGAAATGCAAGACGTTAAGTATCCCATAATTATAGACCAAAACTATTGTGATCGAGTTGAACCATGTATACAACAGTTTTCAGCAGTTCAAGTGAAAAATGTGGTGTATGAGAATATCAAGGGCACAAGTGCAACAAAGGTGGCCATAAAAATTTGATTGCAGCACAAACTTTCCATGTGAAGGAATTATAATGGAGAATATAAATTTAGTAGGGGAAAGTGGAAAACCATCAGAGGCTACGTGCAAAAATGTCCATTTTAACAATGCTGAACATGTTACACCACACTGCACTTCACTAGAAATTTCAGAGGATGAAGCTCTTTTGTATAATTATTAA

[0112] >SEQ ID NO:2 SlPG2a amino acid original(457 aa):

[0113] MVIQRNSILLLIIIFASSISTCRSNVIDDNLFKQVYDNILEQEFAHDFQAYLSYLSKNIESNNNIDKVDKNGIKVINVLSFGAKGDGKTYDNIAFEQAWNEACSSRTPVQFVVPKNKNYLLKQITFSGPCRSSISVKIFGSLEASSKISDYKDRRLWIAFDSVQNLVVGGGGTINGNGQVWWPSSCKINKSLPCRDAPTALTFWNCKNLKVNNLKSKNAQQIHIKFESCTNVVASNLMINASAKSPNTDGVHVSNTQYIQISDTIIGTGDDCISIVSGSQNVQATNITCGPGHGISIGSLGSGNSEAYVSNVTVNEAKIIGAENGVRIKTWQGGSGQASNIKFLNVEMQDVKYPIIIDQNYCDRVEPCIQQFSAVQVKNVVYENIKGTSATKVAIKFDCSTNFPCEGIIMENINLVGESGKPSEATCKNVHFNNAEHVTPHCTSLEISEDEALLYNY*

[0114] >SEQ ID NO:3 SlPG2a CDS edited (1366 bp):

[0115]

[0116] >SEQ ID NO:4 SlPG2a amino acid edited(159 aa)

[0117] MVIQRNSILLLIIIFASSISTCRSNVIDDNLFKQVYDNILEQEFAHDFQAYLSYLSKNIESNNNIDKVDKNGIKVINVLSFGAKGDGKTYDNIAFEQAWNEACSSRTPVQFVVPKNKNYLLKQITFSGPCRSSISVKIFGSLEASSKISDYKEKALDCF*

[0118] >SEQ ID NO:5 site1

[0119] AGACTACAAAGATAGAAGGC

[0120] >SEQ ID NO:6 site2

[0121] GCCACCATACTTGTCCATTG

[0122] >SEQ ID NO:7 site3

[0123] GAAGCATCTAGTAAAATTTC

[0124] >SEQ ID NO:8 site4

[0125] TGGAATTGCAAAAATTTGAA

[0126] >SEQ ID NO:9 site5

[0127] TTGCAAAATAAATAAATCAC

[0128] >SEQ ID NO:10 PG2a-F

[0129] CAAAGTAAACGAAATAACAATAGG

[0130] >SEQ ID NO:11 PG2a-R

[0131] TTAACGTACCGTTGGTGCAT

[0132] >SEQ ID NO:12 part of SlPG2a original genome sequences:

[0133] CAAAGTAAACGAAATAACAATAGG AATAATACTCATAAATGAAAATTTAGTGGCTTTCGTACTACATAATCTTAGTTTATTCATTGTTTCTTTAATTTCCCTTCTTATTTTTTTTGAAATTACTATGCAGATTTTTGGATCCTTAGAAGCATCTAGTAAAAT TTCAGACTACAAAGATAGAAGGC TTTGGATTGCTTTTGATAGTGTTCAAAATTTAGTTGTTGGAGGAGGAGGAACTATCAATGG CAATGGACAAGTATGGTGGCCAA GTTCTTGCAAAATAAATAAATCACTGGTAATTTTATAACCTTGCTTATAAGTTTTACGCTATGTTGCTCGAATTCTTTAAACTTGTTCTAAAGATATTATATATTTGAAGGAGGTGTCACAAATGCATCACATTTTTAGAGATTCCGACCAATATTAGTTTTATGTAATCTAATTTTCAGAGCATCTTTGCCTTGTACTGATCATTGTTACCCTTTTTTTCTTCATGCAGCCATGCAGGG ATGCACCAACGGTACGTTAA

[0134] >SEQ ID NO:13 eTraC

[0135] MSVSFSLNAKKIRLENYAMKMRLYPSPTQAEQMDKMFLALRLAYNMTFHEVFQQNPAVCGDPDEDGNVWPSYKKMANKTWRKALIDQNPAIAEAPAAAITTNNGLFLSNGQKAWKTGMHNLPANKADRKDFRFYSLRKPRRSFAVQIRPRCIIPSDTNQKVARIKLPKIDGAIKARGFNRKIWFGPDGKHTYEEALAAHELSNNLTVRVSKDTCGDYFICITFSQGKVKGDKPTWEFYQEVRVSPIPEPIGLDVRIKDIAILNTGTKYENKQFKRDRAATLKKMSRQLSRRWGPANSAFRDYNKNIRAENRALERAQQDPGSSGVGPEAPVLKSVAQPSRRYLTIQKNRAKLERKIARRRDTYYHQVTARVAGKSSLLAVETLRVKNMLQNHRLAFALSDAAMSDFISKLKYKARRIQVPLVAIGTFQPSSQTCSVCGSINPAVKNLSIRVWTCPNCGTRHNRDINAAKNILAIAQNMLEKKVPFADEALPDEKPPAAPVKKAARKPRDAVFPDHPDLVIRFSKELTQLNDPRYVIVNKATNQIVDNAQGAGYRSAAKAKNCYKAKLAWSSKTNK

[0136] SEQ ID NO:14 SlPG2a original genome sequences (5650 bp):

[0137] TA GAAGGCTTTGGATTGCTTTTGATAGTGTTCAAAATTTAGTTGTTGGAGGAGGAGGAACTATCAATGG CAATGG

[0138] SEQ ID NO:15 SlPG2a edited genome sequences (5642 bp):

[0139]

Claims

1. A tomato plant cell of non-reproductive material that has been modified, the tomato plant cell comprising a mutant S1PG2a gene, the mutant S1PG2a gene comprising: Positions 1928 to 1947 in SEQ ID NO: 14 are subjected to insertion or deletion mutation, and / or positions 2009 to 2028 in SEQ ID NO: 14 are subjected to insertion or deletion mutation.

2. The tomato plant cell according to claim 1, wherein The mutated SlPG2a gene includes: an insertion or deletion of nucleotides between positions 1939 and 1942 in SEQ ID NO: 14, and / or an insertion or deletion of nucleotides between positions 2009 and 2014 in SEQ ID NO:

14.

3. The tomato plant cell according to claim 1, wherein The mutated SlPG2a gene includes: a deletion of nucleotides 1940 to 1941 in SEQ ID NO:14, and / or a deletion of nucleotides 2009 to 2014 in SEQ ID NO:

14.

4. The tomato plant cell according to any one of claims 1 to 3, wherein The tomato plant cell comprises a mutant S1PG2a protein; The amino acid sequence of the mutated S1PG2a protein is shown in SEQ ID NO:

4.

5. The tomato plant cell according to any one of claims 1 to 3, wherein The tomato plant cell comprises a nucleotide sequence that edits the mutant S1PG2a protein.

6. The tomato plant cell according to claim 5, wherein The genomic sequence of the mutant SlPG2a protein is shown in SEQ ID NO:15; the CDS sequence of the mutant SlPG2a protein is shown in SEQ ID NO:

3.

7. A nucleic acid molecule encoding the mutated SlPG2a protein shown in SEQ ID NO:

4.

8. The nucleic acid molecule according to claim 7, wherein the nucleic acid molecule based on the genome is shown in SEQ ID NO: 15, and the nucleic acid molecule based on the CDS sequence is shown in SEQ ID NO:

3.

9. A method for obtaining a tomato plant, wherein all or part of the cells of the tomato plant are modified by gene editing, physical mutagenesis and / or chemical mutagenesis to express the mutated SlPG2a protein shown in SEQ ID NO:4 and / or the endogenous SlPG2a gene of the tomato plant is mutated into the nucleic acid molecule as described in claim 7 or 8.

10. The method according to claim 9, wherein: The gene editing tool is CRISPR-Cas nuclease or its derivative technology, zinc finger nuclease or its derivative technology (ZFN) or transcription activator-like effector (TALE) or its derivative technology; Optionally, the CRISPR-Cas nuclease is a TraC effector protein, preferably an eTraC protein, whose amino acid sequence is shown in the amino acid sequence of SEQ ID NO: 13.

Citation Information

Patent Citations

  • Application of SlEXP1 and SlCEL2 genes in improvement of storage and transportation performance of tomato fruits

    CN116355952A

  • Novel regulatory protein

    US20040191790A1